Copyright
©2010 Baishideng.
World J Gastroenterol. Apr 14, 2010; 16(14): 1776-1781
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1776
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1776
Table 3 Relapse rate by characteristics
| n (%) | P | |
| Age at diagnosis | ||
| < 13 yr (n = 13) | 9 (69.2) | 0.553 |
| ≥ 13 yr (n = 23) | 15 (65.2) | |
| Involvement | ||
| Colon (n = 10) | 5 (50.0) | 0.416 |
| Terminal ileum (n = 3) | 2 (66.7) | |
| Small and large bowel (n = 23) | 17 (73.1) | |
| PCDAI at diagnosis | ||
| < 30 (n = 11) | 7 (63.6) | 0.544 |
| ≥ 30 (n = 25) | 17 (68.0) |
- Citation: Lee JS, Lee JH, Lee JH, Lee HJ, Kim MJ, Lee HJ, Choe YH. Efficacy of early treatment with infliximab in pediatric Crohn’s disease. World J Gastroenterol 2010; 16(14): 1776-1781
- URL: https://www.wjgnet.com/1007-9327/full/v16/i14/1776.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i14.1776